CVS Stock Overview
CVS Health Corporation provides health solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$74.11 |
| 52 Week High | US$81.81 |
| 52 Week Low | US$65.67 |
| Beta | 0.51 |
| 1 Month Change | 0.82% |
| 3 Month Change | -7.83% |
| 1 Year Change | -0.84% |
| 3 Year Change | -8.29% |
| 5 Year Change | 41.38% |
| Change since IPO | 26.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVS | CL Healthcare | CL Market | |
|---|---|---|---|
| 7D | 0% | 5.5% | 1.2% |
| 1Y | -0.8% | 7.9% | 16.6% |
Return vs Industry: CVS underperformed the CL Healthcare industry which returned 7.9% over the past year.
Return vs Market: CVS underperformed the CL Market which returned 16.6% over the past year.
Price Volatility
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 2.5% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 3.0% |
| 10% most volatile stocks in CL Market | 4.9% |
| 10% least volatile stocks in CL Market | 1.5% |
Stable Share Price: CVS has not had significant price volatility in the past 3 months.
Volatility Over Time: CVS's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVS fundamental statistics | |
|---|---|
| Market cap | US$85.02b |
| Earnings (TTM) | US$8.34b |
| Revenue (TTM) | US$356.62b |
10.2x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVS income statement (TTM) | |
|---|---|
| Revenue | US$356.62b |
| Cost of Revenue | US$303.35b |
| Gross Profit | US$53.28b |
| Other Expenses | US$44.93b |
| Earnings | US$8.34b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
| Earnings per share (EPS) | 6.62 |
| Gross Margin | 14.94% |
| Net Profit Margin | 2.34% |
| Debt/Equity Ratio | 78.6% |
How did CVS perform over the long term?
See historical performance and comparison